Form 8-K - Current report:
SEC Accession No. 0001104659-26-043425
Filing Date
2026-04-15
Accepted
2026-04-15 06:05:45
Documents
14
Period of Report
2026-04-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2611763d1_8k.htm   iXBRL 8-K 39904
2 EXHIBIT 99.1 tm2611763d1_ex99-1.htm EX-99.1 11160
7 GRAPHIC tm2611763d1_ex99-1img001.jpg GRAPHIC 23323
  Complete submission text file 0001104659-26-043425.txt   303321

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gpcr-20260415.xsd EX-101.SCH 3892
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gpcr-20260415_def.xml EX-101.DEF 26797
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gpcr-20260415_lab.xml EX-101.LAB 37059
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gpcr-20260415_pre.xml EX-101.PRE 25421
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2611763d1_8k_htm.xml XML 5709
Mailing Address 601 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 (650) 457-1978
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41608 | Film No.: 26862449
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)